ROIV
Roivant Hits High Gear: CEO Matt Gline Outlines Thrilling Q1 Earnings and Future Plans
Roivant, a biotech company with a portfolio of innovative therapies, announced strong progress in its first quarter earnings call for 2027. Despite describing the current quarter as 'quiet', CEO Matt Gline painted a picture of a company poised for significant growth and milestones ahead. The key highlight from